Cardiovascular - Antibody (3)
|
Modality |
Indication |
Targets |
Stage |
Company |
Project No. |
Detail |
| 1 |
Development of an AI-assisted immune cell-targeted anti-Inflammatory **** lead antibody for atherosclerosis |
| Antibody |
Atherosclerosis |
**** |
Lead |
IMVASTECH |
RS-2026-25502996 |
|
| 2 |
Development of a bispecific antibody targeting **** biparatopically for treating cancer-associated pulmonary embolism |
| Antibody |
Cancer-associated pulmonary embolism |
**** |
Candidate |
MabTics Co., Ltd. |
RS-2026-25502741 |
|
| 3 |
|
| Antibody |
Pulmonary hypertension |
KARS1 |
Phase 1 |
Zymedi |
RS-2023-00283541 |
|